Anticoagulation is encountered in nearly all disciplines of medicine. The challenging multidisciplinary consultations relate to simultaneous high risk of thrombosis and bleeds, including surgery and trauma. Meet the expert to learn and discuss further on anticoagulation challenges and solutions.
Riitta Lassila, the Finnish Blood Disease Research Foundation: Introduction
Adam Cuker: “Measurement and Reversal of the Direct Oral Anticoagulants”
Questions and discussion
Taru Kuittinen, hematologist: National experience on direct oral anticoagulants
Conclusive remarks and closure
Assistant Professor of Medicine and Pathology & Laboratory Medicine at the University of Pennsylvania
He received his M.D. from Yale University and completed an internship and residency in internal medicine at Brigham and Women’s Hospital and Harvard Medical School. He continued his postgraduate training at the Hospital of the University of Pennsylvania where he was a fellow in hematology/oncology. He holds a Masters degree in Translational Research from the University of Pennsylvania. He is Director of the Penn Comprehensive Hemophilia & Thrombosis Program, Assistant Director of the Penn Specialized Coagulation Laboratory, and Associate Director of the Penn-CHOP Blood Center for Patient Care and Discovery. He conducts NIH-funded patient-oriented research on heparin-induced thrombocytopenia, venous thromboembolism, and anticoagulation. He is Chair of the forthcoming American Society of Hematology guidelines on venous thromboembolism.
THE FINNISH BLOOD DISEASE RESEARCH FOUNDATION
The mission of Blood Disease Research Foundation is to support hematological research, e.g. by donating grants for thesis work and abstract presentations in major hematological meetings and to promote education.
Educational grant support by BMS-Pfizer, Finland